v3.23.1
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   633.0      
Beginning balance at Dec. 31, 2021 $ 4,775.0 $ 0.0 $ 11,140.0 $ (7.0) $ (6,358.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (19.0)       (19.0)
Other comprehensive income (loss) (5.0)     (5.0)  
Exercise of common stock options (in shares)   1.0      
Exercise of common stock options 12.0   12.0    
Issuance of common stock upon settlement of RSUs, net of shares withheld for taxes (in shares)   2.0      
Issuance of common stock upon settlement of RSUs, net of shares withheld for taxes (224.0)   (224.0)    
Stock-based compensation 198.0   198.0    
Ending balance (in shares) at Mar. 31, 2022   636.0      
Ending balance at Mar. 31, 2022 4,737.0 $ 0.0 11,126.0 (12.0) (6,377.0)
Beginning balance (in shares) at Dec. 31, 2022   631.0      
Beginning balance at Dec. 31, 2022 5,560.0 $ 0.0 11,557.0 (32.0) (5,965.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 117.0       117.0
Other comprehensive income (loss) $ 2.0     2.0  
Exercise of common stock options (in shares) 2.0 2.0      
Exercise of common stock options $ 17.0   17.0    
Issuance of common stock upon settlement of RSUs, net of shares withheld for taxes (in shares)   1.0      
Issuance of common stock upon settlement of RSUs, net of shares withheld for taxes (155.0)   (155.0)    
Stock-based compensation $ 243.0   243.0    
Repurchases of common stock (in shares) (4.0) (4.0)      
Repurchases of common stock $ (492.7)       (493.0)
Ending balance (in shares) at Mar. 31, 2023   630.0      
Ending balance at Mar. 31, 2023 $ 5,291.0 $ 0.0 $ 11,662.0 $ (30.0) $ (6,341.0)